Show simple item record

Files in this item


Item metadata

dc.contributor.authorVincent, I.M.
dc.contributor.authorWeidt, S.
dc.contributor.authorRivas, L.
dc.contributor.authorBurgess, K.
dc.contributor.authorSmith, T.K.
dc.contributor.authorOuellette, M.
dc.identifier.citationVincent , I M , Weidt , S , Rivas , L , Burgess , K , Smith , T K & Ouellette , M 2014 , ' Untargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolism ' , International Journal for Parasitology: Drugs and Drug Resistance , vol. 4 , no. 1 , pp. 20-27 .
dc.identifier.otherPURE: 118160928
dc.identifier.otherPURE UUID: ec28932e-1869-49d4-9025-c62eb3c6525a
dc.identifier.otherScopus: 84890194600
dc.identifier.otherPubMed: 24596665
dc.identifier.otherWOS: 000331708400003
dc.descriptionThis work was funded by the Canadian Institutes of Health Research (Grant number 13233). The Polyomics facility at the University of Glasgow is funded by The Wellcome Trust and the Scottish Universities Life Science Alliance. L.R. is funded by Ministerio de Economía y Competitividad (FIS PI 12-02706). T.K.S. is supported by a Wellcome Trust Grant 093228.en
dc.description.abstractThere are many theories as to the mode of action of miltefosine against Leishmania including alterations to the membrane lipid content, induction of apoptosis and modulation of macrophage responses. Here we perform untargeted metabolomics to elucidate the metabolic changes involved in miltefosine action. Over 800 metabolites were detected, 10% of which were significantly altered after 3.75. h. Many of the changes related to an increase in alkane fragment and sugar release. Fragment release is synchronised with reactive oxygen species production, but native membrane phospholipids remain intact. Signs of DNA damage were also detected as were changes to the levels of some thiols and polyamines. After 5. h of miltefosine treatment the cells showed depleted levels of most metabolites, indicating that the cells' outer membrane integrity had become compromised and internal metabolites were escaping upon cell death. In miltefosine resistant cells, the drug was not internalised and the changes to the internal metabolite levels were not seen. In contrast, cells resistant to antimony (SbIII) had similar corresponding alterations to the levels of internal metabolites as wild-type cells. A detailed knowledge of the mode of action of miltefosine will be important to inform the design of combination therapies to combat leishmaniasis, something that the research community should be prioritising in the coming years.
dc.relation.ispartofInternational Journal for Parasitology: Drugs and Drug Resistanceen
dc.rights© 2013 The Authors. Published by Elsevier Ltd. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.en
dc.subjectMode of actionen
dc.subjectRM Therapeutics. Pharmacologyen
dc.titleUntargeted metabolomic analysis of miltefosine action in Leishmania infantum reveals changes to the internal lipid metabolismen
dc.typeJournal articleen
dc.contributor.sponsorThe Wellcome Trusten
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Biologyen
dc.contributor.institutionUniversity of St Andrews. Biomedical Sciences Research Complexen
dc.description.statusPeer revieweden

This item appears in the following Collection(s)

Show simple item record